Federal prosecutors have charged both the former CEO and president of a New Jersey pharmaceutical company with illegally conspiring to fix prices on generic drugs, marking the first time the Justice Department’s Antitrust Division has prosecuted a case involving generic medications, and could be the first domino in a series of charges still to come against others. [More]
